SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-22-034420
Filing Date
2022-02-10
Accepted
2022-02-10 16:05:54
Documents
4
Group Members
ELI LILLY S.A.

Document Format Files

Seq Description Document Type Size
1 SC 13G d299755dsc13g.htm SC 13G 55492
2 EX-99.1 d299755dex991.htm EX-99.1 6148
3 EX-99.2 d299755dex992.htm EX-99.2 4525
4 EX-99.3 d299755dex993.htm EX-99.3 4778
  Complete submission text file 0001193125-22-034420.txt   72795
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filed by) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY
Business Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY 01235 5430281
Immunocore Holdings plc (Subject) CIK: 0001671927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92246 | Film No.: 22613905
SIC: 2836 Biological Products, (No Diagnostic Substances)